Detalles de la búsqueda
1.
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials.
Am J Cardiovasc Drugs
; 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734847
2.
Safety and efficacy of sotagliflozin in patients with type II diabetes mellitus and chronic kidney disease: a meta-analysis of randomized controlled trials.
J Nephrol
; 2023 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38141092
3.
Cardiovascular benefits of GLP-1 receptor agonists in patients living with obesity or overweight: a meta-analysis of randomized controlled trials
Am. j. cardiovasc. drugs
; maio.2024. ilus
Artículo
en Inglés
| CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1554136
Resultados
1 -
3
de 3
1
Próxima >
>>